| Literature DB >> 32377288 |
Paola Aiello1,2, Maedeh Sharghi3, Shabnam Malekpour Mansourkhani4, Azam Pourabbasi Ardekan5, Leila Jouybari6, Nahid Daraei7, Khadijeh Peiro8, Sima Mohamadian9, Mahdiyeh Rezaei9, Mahdi Heidari5, Ilaria Peluso1, Fereshteh Ghorat10, Anupam Bishayee11, Wesam Kooti5.
Abstract
The standard treatment for cancer is generally based on using cytotoxic drugs, radiotherapy, chemotherapy, and surgery. However, the use of traditional treatments has received attention in recent years. The aim of the present work was to provide an overview of medicinal plants effective on colon cancer with special emphasis on bioactive components and underlying mechanisms of action. Various literature databases, including Web of Science, PubMed, and Scopus, were used and English language articles were considered. Based on literature search, 172 experimental studies and 71 clinical cases on 190 plants were included. The results indicate that grape, soybean, green tea, garlic, olive, and pomegranate are the most effective plants against colon cancer. In these studies, fruits, seeds, leaves, and plant roots were used for in vitro and in vivo models. Various anticolon cancer mechanisms of these medicinal plants include induction of superoxide dismutase, reduction of DNA oxidation, induction of apoptosis by inducing a cell cycle arrest in S phase, reducing the expression of PI3K, P-Akt protein, and MMP as well; reduction of antiapoptotic Bcl-2 and Bcl-xL proteins, and decrease of proliferating cell nuclear antigen (PCNA), cyclin A, cyclin D1, cyclin B1 and cyclin E. Plant compounds also increase both the expression of the cell cycle inhibitors p53, p21, and p27, and the BAD, Bax, caspase 3, caspase 7, caspase 8, and caspase 9 proteins levels. In fact, purification of herbal compounds and demonstration of their efficacy in appropriate in vivo models, as well as clinical studies, may lead to alternative and effective ways of controlling and treating colon cancer.Entities:
Mesh:
Substances:
Year: 2019 PMID: 32377288 PMCID: PMC7187726 DOI: 10.1155/2019/2075614
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Cytotoxic effects of medicinal plants on colon cancer in in vitro models.
| Scientific name | Parts used | Cell line | Conc. | Type of extract | Important compounds | Cellular effect | Mechanisms | References |
|---|---|---|---|---|---|---|---|---|
|
| Fruit | HCT116 | NM |
| Hydroxycinnamic acids, proanthocyanidins, stilbenoids | Increase of dihydroceramides, sphingolipid mediators involved in cell cycle arrest, and reduction of the proliferation rate | (i) Increase of p53 and p21 cell cycle gate keepers | [ |
| Fruit | Caco-2 | 365 mg/g |
| Catechin, epicatechin, quercetin, gallic acid | Antiproliferative activity and direct initiation of cell death | Blockage in the G2/M phase | [ | |
| Seed | Caco-2 | 10–25 |
| Procyanidins | (i) Increased crypt depth | Reduced MPO (myeloperoxidase) activity | [ | |
| Skin | NM | 7.5, 30, 60 |
| 4′-Geranyloxyferulic acid | NM | NM | [ | |
| Seed | Colon cancer stem cells | 6.25, 12.5, 25 |
| (+)-catechin, (−)-epicatechin | NM | (i) Increment of p53, Bax/Bcl-2 ratio, and cleaved PARP | [ | |
|
| ||||||||
|
| Root | HT-29 | 20, 50, 100 mg/mL |
| NM | Induction of apoptosis and cell cycle arrest | (i) Inhibition of the PI3K̸Akt pathway | [ |
|
| ||||||||
|
| Seed | Caco-2, SW620, HT-29 | 12.5 |
| Anthoxanthin | Cell death and significant reduction of cell density | Enhancement of Rab6 protein levels | [ |
| Seed | HT-29 | 240, 600 ppm |
| Saponin | Suppression of PKC activation and increase of alkaline phosphatase activity | [ | ||
| Seed | HT-29 | NM |
| Saponin | NM | (i) Suppression of the degradation of I | [ | |
|
| ||||||||
|
| Leaf | HT-29 | 0, 10, 30, 50 |
| Catechin, epigallocatechin gallate | 1.9-fold increase in tumor cell apoptosis and a 3-fold increase in endothelial cell apoptosis | (i) Suppression of ERK-1 and ERK-2 activation | [ |
| Leaf | Caco-2, HT-29 | 300 |
| Theaflavins (TF-2T, F-3, TF-1) | Human colon cancer cell apoptosis induction | Modulation of NF | [ | |
| Leaf | HT-29 | 68-80 |
| Flavan-3-ol (catechin & tannin) & polyphenols (teadenol B) | Inhibition of proliferation of HT-29 cells | Increased expression levels of caspases 3/7, 8, and 9 | [ | |
|
| ||||||||
|
| Fruit | HT-29 | 150, 55.5 |
| Maslinic acid, oleanolic acid | Antiproliferative activity | (i) Increased caspase 3-like activity to 6-fold | [ |
| Fruit, leaf | SW480 and HT-29 | 100–400 m/z |
| Oleic acid, linoleic acid, gamma-linolenic acid, lignans, flavonoids, secoiridoids | Reduced cell growth in both cell lines | (i) Limited G2M cell cycle | [ | |
| Fruit | Caco-2 | 50 |
| Phenolic compounds, authentic hydroxyl tyrosol (HT) | Reduced proliferation of Caco-2 cells | Reduction of the methylation levels of CNR1 promoter | [ | |
| Fruit | HT115 | 25 |
| Phenolic compounds (p-hydroxyphenyl ethanol, pinoresinol & dihydroxyphenyl ethanol) | NM | Inhibition by reduced expression of a range of | [ | |
| Olive mill wastewater | HT-29, HCT116, CT26 | NM |
| Hydroxytyrosol | (i) Inhibited proliferation | (i) Reduced sprout formation | [ | |
| Fruit | Caco-2 | 0-2,000 |
| Tyrosol, hydroxytyrosol, oleuropein, rutin, quercetin and glucoside forms of luteolin and apigenin | NM | (i) Induction of the cell cycle arrest in S-phase | [ | |
|
| ||||||||
|
| Juice | HT-29 | 50 mg/L |
| Ellagitannins, punicalagin | Inhibition of cancer cell proliferation | (i) Suppressed TNFR-induced COX-2 protein expression | [ |
| Seed | LS174 | 63.2 |
| Punicic acid, | Cytotoxic activity | (i) Slightly decreased development of tubules from elongated cell bodies | [ | |
|
| ||||||||
|
| Root | HT-29 | 12.2 and 31 |
| Licochalcone | NM | Increase of the protein levels of proapoptotic Bax | [ |
|
| ||||||||
|
| Fruit | Caco-2 | 115 |
| Betalain pigment indicaxanthin | Apoptosis of proliferating cells | (i) Demethylation of the tumor suppressor p16INK4a gene promoter | [ |
| Fruit | HT-29 & Caco-2 & NIH 3 T3 (as control) | Against HT-29 (4.9 |
| Isorhamnetin glycosides (IG5 and IG6)-phenol | Cell death through apoptosis and necrosis | Increased activity of caspase 3/7 | [ | |
|
| ||||||||
|
| Leaf | HT-29 and HCT116 | 200.0 |
| Hydroxychavicol | Antioxidant capacity and induction of a greater apoptotic effect | (i) Scavenging activity | [ |
|
| ||||||||
|
| Fruit | HT-29 | 0.025, 0.05, 0.25, 0.5% |
| Ascorbate, ellagic acid | Decreased proliferation of HT-29 cells | Increase in the levels of 8OHA and decrease in the levels of 8OHG | [ |
|
| ||||||||
|
| Leaf | HT-29 HCT116 | 0, 100, 200, 300 mg/L |
| p-Coumaric acid, tricin | Inhibited colony formation | Nonadherent sphere formation suppressed CD133+ & CD44+ population | [ |
|
| ||||||||
|
| Stem | HCT116, COLO 205 | 10, 20, 40,60, 80, 100 mg/L |
| Terpenoids, phenolic acid, flavonoids, dibenzylcyclooctadiene | Apoptosis & loss of mitochondrial membrane | Induced G0/G1 cell cycle | [ |
|
| ||||||||
|
| Fruit | HT-29, HT-115, Caco-2 | 3.125, 6.25, 12.5, 25, 50 mg/L |
| Polyphenol, anthocyanin, ellagitannin | NM | Decreased population of cells in G1 phase | [ |
| LoVo | 50 |
| NM | Inhibited proliferation of LoVo | Suppression of the NF | [ | ||
|
| ||||||||
|
| Root | HT-29, HCT15, DLD1, HCT116 | (i) Short-term assay: four 10-fold dilutions (100 to 0.1 mg/L) |
| Curcumin (diferuloylmethane) | Inhibited formation of HCT116 spheroids | NM | [ |
|
| ||||||||
|
| Root | HCT116 | 12.5, 25, 50, 100 |
| Eleutherosides, triterpenoid saponins, glycans | NM | Activation of natural killer cells and thus enhancement of immune function | [ |
|
| ||||||||
|
| Leaf | HT-29, HCT15 | 10, 30, 100 mg/L |
| Alkaloids | NM | Inhibited the unwinding of supercoiled DNA | [ |
|
| ||||||||
|
| Root, flower, leaf | RKO | 50, 100, 200, 400, 800 mg/L |
| Phenylethanoid glycoside, squalene, salidroside, 2-phenyl rutinoside | Apoptosis induction | (i) Increase of fragmented DNA | [ |
| Powder | RKO | 200, 400, 800 |
| Water soluble compounds | Antiproliferative effect | NM | [ | |
|
| ||||||||
|
| Seed | Caco-2, Cat. No. HTB-37 | 16.11 |
| Cyanidin-3-glucoside and peonidin-3-glucoside, anthocyanins, phenolic compounds | (i) Antioxidation of anthocyanins and phenols | NM | [ |
|
| ||||||||
|
| Leaf | HCT116, HT-29 | 11.43 ± 1.87 |
| Alkaloids, acetogenins, essential oils | Block of the migration and invasion of HT-29 and HCT116 cells | (i) Cell cycle arrest at G1 phase | [ |
| NM | HT-29, HCT116 | <4, <20 |
| Annopentocin A, annopentocin B, annopentocin C, cis- and trans-annomuricin-D-ones, annomuricin E | NM | Suppression of ATP production and NADH oxidase in cancer cells | [ | |
|
| ||||||||
|
| Leaf | HCT116 | NM |
| Resin, known as Chios mastic gum (CMG) | Causes several morphological changes typical of apoptosis in cell organelles | (i) Induction of cell cycle arrest at G1 phase | [ |
| Resin | HCT116 | 100 |
| Caryophyllene | Induction of the anoikis form of apoptosis in human colon cancer HCT116 cells | (i) Induction of G1 phase arrest | [ | |
|
| ||||||||
|
| Biological constituents | HCT116 | 0-2.0 mg/mL |
| Ginseng (GE) or its ginsenoside (GF) and polysaccharide (PS) | Proliferation was inhibited by GE, GF, and PS in wild-type and p21 cells | (i) Cells arrest in G0/G1 phase and increment of p53 and p21 proteins | [ |
|
| ||||||||
|
| Fruit | Colon cancer stem cells | 5.0 |
| Anthocyanin, | Critical regulator of CSC proliferation and its downstream proteins (c-Myc and cyclin D1) and elevated Bax and cytochrome c | (i) Cytochrome c levels were elevated regardless of p53 status | [ |
|
| ||||||||
|
| Leaf | HT-29 | NM |
| Polysaccharides, oligosaccharides | Changes in genes involved or linked to cell cycle arrest | (i) Inactivation of the retinoblastoma phosphoprotein | [ |
|
| ||||||||
|
| Fruit | HT-29 | 5.8 ± 1.0, 7.5 ± 2.0, 12 ± 1% ( |
| Betacyanins, flavonoids (isorhamnetin derivatives) and phenolic acids (ferulic acid) | NM | Induced cell cycle arrest at different checkpoints—G1, G2/M, and S | [ |
|
| ||||||||
|
| NM | HCT15 | 400 |
| Protocatechuic acid, cinnamic acid, | (i) Increase in the cellular levels of p-H2A.X, which is suggestive of DNA damage | (i) Inhibition of cell proliferation in G1 phase | [ |
|
| ||||||||
|
| Leaf | HT-29 | 0.63 |
|
| Arrest of cell growth was observed with | NM | [ |
|
| ||||||||
|
| Leaf | SW 620, DLD-1 | 0-120 |
| Polyphenols | Antiproliferative effect of 5-FU | Downregulation of TYMS and TK1, enzymes related to 5-FU resistance | [ |
| Leaf | HT-29 | SC-RE 30 |
| Polyphenols (carnosic acid (CA) and carnosol) | (i) Upregulation of VLDLR gene as the principal contributor to the observed cholesterol accumulation in SC-RE-treated cells | Activation of Nrf2 transcription factor and common regulators, such as XBP1 (Xbp1) gene related to the unfolded protein response (UPR) | [ | |
| NM | HT-29 | 10, 20, 30, 40, 50, 60, 70 |
| Carnosic acid, carnosol, rosmarinic acid, rosmanol | NM | NM | [ | |
| Leaf | HGUE-C-1, HT-29, and SW480 | 20–40 mg/mL |
| Carnosic acid, carnosol, and betulinic acid | NM | (i) Prooxidative capability by increasing the intracellular generation of ROS | [ | |
|
| ||||||||
|
| Leaf | HT-29 | 50 mg/mL |
| Bergapten, isoimpinellin, xanthotoxin, imperatorin, panaxydiol, falcarindiol, falcarinol | Induced apoptosis by the decreased expression of the antiapoptotic Bcl-2 mRNA | (i) Reduced expression of Bcl-2 | [ |
|
| ||||||||
|
| Leaf | HCT116 | 20 mg/mL |
| Phenylethanoid glycosides, diacetyl-O-isoverbascoside, diacetyl-O-betonyoside A, and diacetyl-O-betonyoside A | (i) Substantial tumor cell growth inhibitory activity | (i) Increased lipophilicity of molecules seemed to be responsible for enhanced cytotoxicity | [ |
|
| ||||||||
|
| Leaf | RCM-1 | 12.5 |
| Acetic acid 3-methylthio propyl ester (AMTP), methyl thio propionic acid ethyl ester (MTPE) | Exhibited antimutagenic activity | Auraptene (7-geranyloxycoumarin) having a monoterpene moiety and | [ |
|
| ||||||||
|
| Seed | SW 480 | 0–100 |
| Corilagin, gallic acid, ellagic acid | (i) Antiangiogenetic properties | Release and expression of VEGF indicated that all fractions showed the anti-VEGF secretion activity | [ |
|
| ||||||||
|
| Flower | Caco-2 | 1/50 dilution of the ethanolic extract |
| Amino acids, including L-arginine and L-canavanine, pinitol, flavonoids, and triterpenoid saponins as well as hexadecanoic acid and | Disruption of the key molecules in the PI3K pathway thereby inducing apoptosis | Decrease in cell viability and increment in pyknosis as well as loss in cellular membrane integrity | [ |
|
| ||||||||
|
| Leaf | HT-29, T84 | 346, 120 |
| Phenolic acids (rosmarinic acid, coumaric acid, caffeic acid, protocatechuic acid, ferulic acid, chlorogenic acid), flavonoids, sesquiterpenes, monoterpenes, triterpenes | (i) Inhibited proliferation of colon carcinoma cells | (i) G2/M cell cycle arrest | [ |
|
| ||||||||
|
| Leaf | HT-29 | 500 mg/mL |
| Fucoidans | (i) Reduction of free radicals | Accumulation of cells in G0/G1 phase | [ |
|
| ||||||||
|
| NM | HT-29 | 400 mg/mL |
| Octadecyl (E)-p-coumarate, P-E-methoxy-cinnamic acid, ferulic acid, scopoletin, succinic acid, aurantiamide acetate, rubiadin | Suppress tumor cell growth and induce the apoptosis of human CRC cells | (i) Block G1/S progression | [ |
|
| ||||||||
|
| Peel | LoVo | 100 mg/mL |
| Linoleic acid methyl ester, | Interesting antiproliferative activity against colorectal carcinoma | NM | [ |
|
| ||||||||
|
| Leaf | LoVo | 413.3 mg/L |
| Scutellarein, scutellarin, carthamidin, isocarthamidin, wogonin | Induce cell death in the human colon cancer cell line | Increase in the sub-G1 phase and inhibition of cell growth | [ |
|
| ||||||||
|
| Resin | HCT116 | 100 |
| Caryophyllene | Induce the anoikis form of apoptosis in human colon cancer HCT116 cells | (i) Induce G1 phase arrest | [ |
|
| ||||||||
|
| Peel | SNU-C4 | 100 |
| Limonene, geranial, neral, geranyl acetate, geraniol, | Induce the apoptosis on SNU-C4, human colon cancer cells | Expression of proapoptotic gene, Bax, and major apoptotic gene, caspase 3 | [ |
|
| ||||||||
|
| Root | COLO320 | 150 mg/mL |
| Caffeic acid derivatives, alkylamides, polyacetylenes, polysaccharides | Induce apoptosis and promote nuclear DNA fragmentation | (i) Induce apoptosis by increasing caspase 3/7 activity | [ |
|
| ||||||||
|
| Leaf | HT-29 | 50 |
| Phenethyl isothiocyanate, 7-methylsulfinylheptyl, 8-methylsulfinyl | (i) Inhibition of initiation, proliferation, and metastasis | (i) Inhibited DNA damage | [ |
|
| ||||||||
|
| NM | SW480, HCT15, HCT116, DLD-1 | 20 and 40 |
| 2,5-Dibromo-3,4-dihydroxybenzyl n-propyl ether | Potentially could be used as a chemopreventive agent against colon cancer | (i) Inhibited Wnt/ | [ |
|
| ||||||||
|
| Stem | HT-29 | 200 |
| Aristolochic acid, nitrophenanthrene carboxylic acids | Inhibition of proliferation and induction of apoptosis in HT-29 cells | (i) Induction of sub-G1 cell cycle | [ |
|
| ||||||||
|
| Leaf | HCT116 | 100 |
| Phenols, flavonoid, betulinic acid | Strong inhibition of microvessel outgrowth | (i) Inhibition of tube formation on Matrigel matrix | [ |
|
| ||||||||
|
| Leaf | HT-29 | 200 mg/mL ( |
| Rosmarinic acid | Inhibits CRC cell growth | (i) Suppresses STAT3 phosphorylation | [ |
|
| ||||||||
|
| Root | HCT116 | 3200 |
| Jaligonic acids, kaempferol, quercetin, quercetin 3-glucoside, isoquercitrin, ferulic acid | Control of growth and spread of cancer cells | Reduction in the expressions of MYC, PLAU, and TEK | [ |
|
| ||||||||
|
| Leaf | HCT15 | 13.8 |
| Epicatechin, myricetin, quercetin hydrate, luteolin, kaempferol, ascorbic acid, gallic acid, pelargonidine, p-coumaric acid | Cytotoxic effect on human colon cancer cells (HCT15) | (i) Apoptosis induction also involved in the downregulation of iNOS | [ |
|
| ||||||||
|
| Leaf | HT-29 | 200 |
| Phenols, tannins, and flavonoids | (i) Antioxidant activity | (i) Scavenge free radicals | [ |
|
| ||||||||
|
| Dried | HCT116 | 20 mg/mL |
| Asarinin and xanthoxylol | Inhibition of the growth of HCT116 cells | (i) Caspase-dependent apoptosis | [ |
|
| ||||||||
|
| Fruit | HT-29 | 500 mg/mL |
| Phenolic and anthocyanin | Reduction of proliferation of colon cancer cells | (i) Cell cycle delay in S phase | [ |
|
| ||||||||
|
| Flower | Caco-2, HCT116 | 0–2,000 mg/mL |
| Cichoric acid | (i) Inhibition of proliferation | (i) Decreased telomerase activity | [ |
| Root | COLO320 | 150 mg/mL |
| Caffeic acid derivatives, alkylamides, polyacetylenes, polysaccharides | Induce apoptosis by increasing significantly caspase 3/7 activity and promote nuclear DNA fragmentation | (i) Increase significantly caspase 3/7 activity | [ | |
|
| ||||||||
|
| Leaf | NM | 100 mg/kg b.w./day |
| Coumarin, lignans, quinones | 30% reduction of tumor-induced neovascularization | NM | [ |
| NM | Caco-2 | NM |
| Phenolic compounds, flavonoid, diterpenes | Digestive, gastroprotective, antiseptic, anti-inflammatory, and antiproliferative activity | NM | [ | |
| Fruit | NL-17 | 0, 50, 100, 150 |
|
| NM | (i) Induction of caspase 3 and caspase 9 activation | [ | |
| Stem, bark | HT-29 | 50 |
|
| Cytotoxic activity against HT-29 human colon cancer | Inhibition of p50 and p65 activation | [ | |
|
| ||||||||
|
| Leaf | HCT116 | 8.98 |
| Acetogenins (annoreticuin & isoannoreticuin) and alkaloids dopamine, salsolinol, and coclaurine | Inhibition of growth and proliferation of tumor cells | (i) Reactive oxygen species (ROS) formation, lactate dehydrogenase (LDH) release | [ |
|
| ||||||||
|
| Stem | HT-29 | 5-15 |
| Benzyls and isoflavones (genistein, coumarins, scandinone) | Apoptosis and mitotic catastrophe of human colon cancer HT-29 cells | (i) Inhibition of | [ |
|
| ||||||||
|
| Aerial parts | HT-29 | 25 |
| Pyrrolizidine alkaloids (senecionine, senkirkine, monocrotaline, echimidine) | Induced alteration of colony morphology | (i) Upregulation of p21 and downregulation of NCL, FOS, and AURKA | [ |
|
| ||||||||
|
| The dermal layer of stalk | HCT116 & colon cancer stem cells | >16 and 103 |
| Apigeninidin & luteolinidin | Antiproliferative | Target p53-dependent and p53-independent pathways | [ |
| Dermal and seed head | CCSC | NM |
| Apigeninidin, luteolinidin, malvidin 3-O-glucoside, apigenin, luteolin, naringenin, naringenin 7-O-glucoside, eriodictyol 5-glucoside, taxifolin, catechins | NM | (i) Elevation of caspase 3/7 activity | [ | |
|
| ||||||||
|
| Seed | HCT116 | KSE (15.625 |
| Gallic acid, p-hydroxybenzoic acid, caffeic acid, vanillic acid, syringic acid, and p-coumaric and ferulic acids | Cytotoxic activity against human colon cancer HCT116 cells | Apoptosis via blockade of mid G1-late G1-S transition thereby causing G1 phase cell cycle arrest | [ |
|
| ||||||||
|
| Bark | HCT116 & HT-29 | 300 |
| Catechin, salicin, catechol and smaller amounts of gallic acid, epigallocatechin gallate (EGCG), quercetin, coumaric acid, rutin, syringic acid, and vanillin | Anticarcinogenic effects in colon cancer cells | Apoptosis via inhibition of phosphatidylinositol 3-kinase/protein kinase B and mitogen-activated protein kinase signaling pathways | [ |
|
| ||||||||
|
| Fruit | HT-29 | 400 |
| Polyphenols, gallic acid, sanguine | Induction of apoptosis | (i) Induced activity of caspases 3, 7, and 9 | [ |
|
| ||||||||
|
| Root | HT-29 | 200 |
| Tannins, saponins, polyphenolics, alkaloids | Apoptosis in human colon tumor HT-29 cells | (i) Induced G0/G1 arrest | [ |
|
| ||||||||
|
| Thorn | HCT116 | 800 |
| Flavonoid, lupine acid, ellagic acid glycosides | (i) Increase in p53 levels | Inhibition of proliferation of colon cancer cells | [ |
| Thorn | HCT116 | 600 |
| NM | Inhibitory effect on proliferation of human colon cancer HCT116 cells | (i) Caused cell cycle arrest at G2/M phase together with a decrease of cyclin B1 and Cdc2 | [ | |
|
| ||||||||
|
| Fruit | DLD-1 | 50 |
| Oleanolic acid, ursolic acid | Inhibited proliferation | (i) Reduction of Tbx3 rescued the dysregulated P14ARF-P53 signaling | [ |
|
| ||||||||
|
| Rhizome | HCT116 | 5 |
| 6-Paradol, 6- and 10-dehydrogingerdione, 6- and 10-gingerdione, 4-, 6-, 8-, and 10-gingerdiol, 6-methylgingerdiol, zingerone, 6-hydroxyshogaol, 6-, 8-, 10-dehydroshogaol, diarylheptanoids | Inhibitory effects on the proliferation of human colon cancer cells | (i) Arrest at G0/G1 phase | [ |
|
| ||||||||
|
| Fruit | HT-29 | 10 ng/mL |
| Phenolic compounds (pyrogallol, caffeic acid, myricetin, protocatechuic acid) | Inhibition of TNBS-induced rat colitis | Induced cell cycle progression in G0/G1 phase | [ |
|
| ||||||||
|
| The enzymatically hydrolyzed epithelium of the edible | HCT116 | <150 |
| Monosulphated triterpenoid glycoside frondoside A, the disulphated glycoside frondoside B, the trisulphated glycoside frondoside C | Inhibition of human colon cancer cell growth | (i) Inhibition at S and G2-M phases with a decrease in Cdc25c and increase in p21WAF1/CIP | [ |
|
| ||||||||
|
| Leaf & twigs | HT-29 | 10 and 5 mg/kg/day |
| Sesquiterpene lactone (13-acetoxyrolandrolide) | Antiproliferative effect against human colon cancer cells | Inhibition of the NF | [ |
|
| ||||||||
|
| Leaf & Fruit | Caco-2 | 250–500 |
| Phenolic compound (flavonol and flavone heterosides, 5-O-caffeoylquinic acid) | Antiproliferative effect against human kidney and colon cancer cells | (i) Suppression of factor activation, nuclear factor-kB (NF | [ |
|
| ||||||||
|
| Fruits | HT-29 | 820 mg/mL |
| Steroids (mainly ergosterol derivatives) & polysaccharides & galactomannan | Antioxidant activity in HT-29 colon cancer cells | Inhibition of NF-B activation in the NF-B assay | [ |
|
| ||||||||
|
| Aerial part | HT-29 | 0–0.5 mg/mL |
| Buddlejasaponin IV | Induced apoptosis in HT-29 human colon cancer cells | Induction of apoptosis via mitochondrial pathway by downregulation of Bcl-2 protein levels, caspase 3 activation, and subsequent PARP cleavage | [ |
|
| ||||||||
|
| Leaf | HT-29 | 500 |
| Uracil, adenine, adenosine, Li-glycyrrhetinic acid, quiritin | NM | Antiproliferative effect determination of the protein levels of p21, cyclin D1, PCNA, and cdk-2, which are the key regulators for cell cycle progression | [ |
|
| ||||||||
|
| Leaf & stem | HT-29 | 2 mg/mL |
| Flavonoids, triterpenoids, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, polysaccharide | Antiproliferation in HT-29 colon cancer cells | Inhibited proliferation at G2 point of the cell cycle and apoptosis via tumor suppressor protein p53 | [ |
|
| ||||||||
|
| Fruit & leaf | HT-29 | 20–320mg/L |
| Terpene lactones and flavonoid glycosides | (i) Inhibited progression of human colon cancer cells | Increase in caspase 3 activities and elevation in p53 MRN reduction in Bcl-2 mRNA | [ |
|
| ||||||||
|
| Seed | HT-29, SW 480, HCEC | 100 |
| Phenolic compound (tricin, ferulic acid, caffeic acid, and methoxycinnamic acid) | Inhibition of the human colon cancer cell growth | (i) Induced apoptosis by enhanced activation of caspases 8 and 3 | [ |
|
| ||||||||
|
| Root | HT-29 | 305.024/mL |
| Osthole, auraptenol, imperatorin | Inhibited proliferation of human colon cancer cells (HT-29) | Inhibition of the cellular proliferation via G0/G1 phase arrest of the cell cycle and induced apoptosis | [ |
|
| ||||||||
|
| Root | HT-29 | 0.1-5 mg/mL |
| N-(3-(Aminomethyl)benzyl)acetamidine | Inhibited the invasiveness of cytokine-treated HT-29 cells through the Matrigel-coated membrane in a concentration-dependent manner | (i) Reduction of HT-29 cell invasion through the Matrigel | [ |
|
| ||||||||
|
| Fruit | HT-29 and HCT116 | 0.10 mg/mL |
| Piperidine alkaloids, piperamides, piperlongumine | (i) Induction of apoptosis, following DNA fragmentation in HT-29 colon cancer cells in a time-dependent manner | Induced whole cell ROS production | [ |
|
| ||||||||
|
| Root | COLO 205 | 50-100 and 150-200 |
| Phenolic compounds | (i) Enhanced growth inhibitory effects of AAA towards COLO 205 cells in contrast to EAA | (i) Triggered mitochondrial apoptosis pathway and S phase cell cycle arrest | [ |
|
| ||||||||
|
| Leaf | HCT116 | 0.2, 0.4, 0.6, 0.8 mg/mL | Carvacrol and thymol | Inhibited proliferation, adhesion, migration, and invasion of cancer cells | [ | ||
|
| ||||||||
|
| NM | SW480 | 40 |
| Cyclozonarone benzoquinone | NM | Induced apoptosis by reducing Bcl-2 levels, upregulating Bax, and disrupting the mitochondrial membrane potential, leading to the activation of caspases 3 and 9 | [ |
|
| ||||||||
|
| NM | HCT116 | 0.25, 0.5, 1.0 mg/mL |
| NM | NM | Upregulation of Bax and caspases 9 and 3 and downregulation of Bcl-2 expression of genes | [ |
|
| ||||||||
|
| Dry flower & leaf | DLD-1 and HCT116 | 0.3–5 |
| Cannabidiol, phytocannabinoids | Reduced cell proliferation in a CB1-sensitive | (i) Reduced AOM-induced preneoplastic lesions and polyps | [ |
|
| ||||||||
|
| Fruit | Caco-2 | 0.2 mg/mL |
| Phenolic acids (gallic, protocatechuic, hydroxybenzoic, vanillic, isovanillic, syringic, caffeic, ferulic, sinapic, p-coumaric, isoferulic), flavonoid glycosides (quercetin, luteolin, apigenin, and kaempferol), and anthocyanidins | Increasing beneficial bacterial growth and inhibition of proliferation of colon cancer cells | NM | [ |
|
| ||||||||
|
| Fruit | SW480, CT26 | 0, 10, 20, 30, 40, 50 |
| Triterpenoids, flavonoids, polysaccharide, limonoids | NM | (i) Inhibited cell proliferation of SW480 and CT26 by promoting apoptosis as indicated by nuclear chromatin condensation and DNA fragmentation | [ |
|
| ||||||||
|
| Flower | HCT116 | 0.25, 0.5, 1, 2, 4 |
| Carotenoid, pigment, crocin, crocetin | Induced DNA damage and apoptosis | (i) Induction of a p53 pattern-dependent caspase 3 activation with a full G2/M stop | [ |
| Tepals and leaf | Caco-2 | 0.42 mg/mL |
| Polyphenols, glycosides of kaempferol, luteolin, and quercetin | Proliferation of Caco-2 cells was greatly inhibited | NM | [ | |
|
| ||||||||
|
| Fruit | HT-29 | 50, 100, and 200 |
| Amariin, echinatin, saponins, hentriacontane, gypsogenin, cucurbitacin B, datiscacin, 2- | Increase in the population of apoptotic cells | (i) Inhibited the cellular proliferation of HT-29 cells via G2/M phase arrest of the cell cycle | [ |
|
| ||||||||
|
| Fruits (wine) | CCD-18Co | 25, 50, 100 | NM | Polyphenolics | NM | (i) Decreased mRNA expression of lipopolysaccharide- (LPS-) induced inflammatory mediators NF | [ |
|
| ||||||||
|
| Dried fruit | HCT116 | 0, 5, 10, 15, 20, 25, 30 |
| Ent-15-oxokaur-16-en-19-oic acid (EOKA) | NM | (i) Induced DNA damage, cell cycle arrest in G1 phase, and apoptotic cell death | [ |
|
| ||||||||
|
| Grain | ER- | 1, 5, 10, 100 |
| Flavones (luteolin and apigenin), 3-deoxyanthocyanins naringenin (eriodictyol and naringenin) | Reduced cell growth via apoptosis | Increased caspase 3 activity | [ |
| NM | HT-29, HCT116 | 0.9-2.0 mg/mL |
| Procyanidin B1, delphinidin-3-O-glucoside, tannin, cyanidin-3-O glucoside | (i) Significantly arrested HT-29 cells in G1 | (i) Downregulation of apoptotic proteins, such as cIAP-2, livin, survivin, and XIAP, was seen in HCT116 cells | [ | |
|
| ||||||||
|
| Root | LoVo and Caco-2 | 0, 100, 250, and 500 |
| Saponin, ginsenoside | NM | Delay in progression of the G0/G1, S, or G2/M cell cycle phases | [ |
|
| ||||||||
|
| Broccoli florets | HCT116 | 0, 1, 2.5, 5, 10 |
| Glucoiberin, 3 hydroxy,4( | NM | NM | [ |
|
| ||||||||
|
| Dried stem | SW480 |
|
| Polysaccharides, phenylethanoid glycosides | (i) Decreased number of mucosal hyperplasia and intestinal helicobacter infection | Decreased frequency of hyperplasia and | [ |
|
| ||||||||
|
| Fruit | Caco-2 and HT-29 | 10, 25, 50, 75, 100, 125, 150 | NM | Procyanidins | NM | NM | [ |
|
| ||||||||
|
| Fruit | SW480, COLO, and WiDr | 150, 300, and 600 |
| Triterpenoid saponins | NM | (i) Inhibited growth and lysed SW480, COLO, and WiDr | [ |
|
| ||||||||
|
| NM | COLO 205 | 50, 100, 200, 300, 400 |
|
| Induced S phase arrest and apoptosis | (i) Induced DNA fragments | [ |
|
| ||||||||
|
| Aerial parts | HCT116, HT-29 | 0, 0.04, 0.12, 0.2, 0.4, 1.2 mg/mL |
| Flavonoids, lignans, and sesquiterpene lactones | NM | (i) Increase in the expression of proapoptotic proteins such as p53, p21, and Bax | [ |
|
| ||||||||
|
| Bulbs | SW480 | 2.5, 5, 10 |
| Eleutherin, isoeleutherin | NM | (i) Inhibited the transcription of TCF/ | [ |
|
| ||||||||
|
| Spears | HCT116 | 76 |
| Steroidal saponins (HTSA-1, HTSAP-2, HTSAP-12, HTSAP-6, HTSAP-8) | NM | (i) Inhibition of Akt, p70S6K, and ERK phosphorylation | [ |
|
| ||||||||
|
| Seed, pulp | HCCSCs, HCT116 | 200 |
| Trigonelline, naringin, kaempferol, embinin, catechin, isorhamnetin, quercetin | (i) Suppressed proliferation | (i) Suppressed cell proliferation and expression of c-Myc and cyclin D1 | [ |
|
| ||||||||
|
| NM | HT-29, HCT116 | 0.9-2.0 mg/mL |
| Delphinidin glycosides, quercetin derivatives, delphinidin-3-O-glucoside (high), cyanidin-3-O-glucoside | (i) Highest growth inhibition | (i) Downregulation of apoptotic proteins, such as cIAP-2, livin, survivin, and XIAP | [ |
|
| ||||||||
|
| NM | HT-29, HCT116 | 0.9-2.0 mg/mL |
| Delphinidin glycosides, procyanidin B1, delphinidin-3-O-glucoside (high), cyanidin-3-O-glucoside | (i) Significantly arrested HT-29 cells in G1 | (i) Downregulation of apoptotic proteins, such as cIAP-2, livin, survivin, and XIAP | [ |
|
| ||||||||
|
| Leaf | Caco-2, BV-2 | 0.2, 0.4, 0.6, 0.8, 1.0 mg/mL |
| Oxalic acid, hydroxybutanedioic acid, gallic acid, quercetin, chlorogenic acid glucans with fucose, xylose, ribose (GW100) arabino-rhamnogalactans (GW100E) | (i) Great potential in antiproliferation | (i) Scavenging | [ |
|
| ||||||||
|
| Flower | SW480 | 200, 370 |
| n-Butanol | Significant antiproliferative effect | (i) Significantly downregulated the expression of Wnt signaling proteins such as | [ |
|
| ||||||||
|
| NM | CT26 | 5, 20, 80 |
| Catalpol | Inhibited proliferation and growth invasion of colon cancer cells | (i) Downregulated MMP-2 and MMP-9 protein expressions | [ |
|
| ||||||||
|
| Bark | HCT116 | 1.5, 2.0 |
| 4-Dicaffeoylquinic acid, quercetin 3-rutinoside, periplocin | NM | (i) Inhibition of | [ |
|
| ||||||||
|
| Root | SW620 | 30 ng/mL |
| Protein hydrolysate | NM | (i) Upregulation of p53 | [ |
|
| ||||||||
|
| Resin | HT-29 | 100, 150 |
| Boswellic acid | Decreased cell viability | (i) Reduction in mPGES-1, VEGF, CXCR4, MMP-2, MMP-9, HIF-1, PGE2 expression | [ |
|
| ||||||||
|
| Leaf | WiDr | 70 |
| Glycoside flavonoid, isovitexin, alkaloids | NM | Inhibition of COX-2 expression | [ |
|
| ||||||||
|
| Fruit | HT-29 | 2,000 |
| Polyphenol | Impaired cell proliferation and invasion | NM | [ |
|
| ||||||||
|
| Leaf | HCT116 | 1,000 mg/mL |
| Gallic acid, quercetin, sinapic acid, ferulic acid, luteolin 7-o-glucoside, hyperoside, isoquercitrin, ellagic acid, isorhamnetin 3-O-rutinoside | Inhibited proliferation | (i) Possession of high DPPH scavenging activity and effective capacity for iron binding | [ |
|
| ||||||||
|
| Root | HT-29 | 10, 20, 30, 40, 50 |
| 11-Hydroxy-12-methoxydihydrokavain, 11-hydroxy-12-methoxydihydrokavain, prenyl caffeate, pinostrobin chalcone, 11-methoxytetrahydroyangonin, awaine, methysticin, dihydromethysticin, 5,6,7,8-tetrahydroyangonin, kavain, 7,8-dihydrokavain, yangonin, desmethoxyyangonin, flavokawain B | Inhibited the growth | NM | [ |
|
| ||||||||
|
| Ground aerial parts | CT26 | 6.76 |
| 19-Deoxyicetexone, 7,20-dihydroanastomosine, icetexone, 19-deoxyisoicetexone | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| Stem | HCT116 | 1, 10, 30, 50 |
| Clerodane furano diterpene glycoside, cordifoliosides A and Β, sitosterol, ecdysterone, 2 | Induced chromatin condensation and fragmentation of nuclei of few cells | (i) Considerable loss of MMP | [ |
|
| ||||||||
|
| Fruit | NM | 35 |
| Vanillic acid, orientin, isoorientin | NM | (i) Scavenging capacity towards ROO and HOCl | [ |
|
| ||||||||
|
| NM | HCT116 | 7.4 ± 1.0, 4.4 ± 0.5 |
| Diterpene quinone | NM | Decreased levels of pro-caspases 3 and 9 | [ |
|
| ||||||||
|
| Bean | HCT116 | 1 mg/mL |
| Chlorogenic acid complex (CGA7) | NM | (i) DNA fragmentation, PARP-1 cleavage, caspase 9 activation, downregulation of Bcl-2 and upregulation of Bax | [ |
|
| ||||||||
|
| Fruit | HCT116 | 10 mg/mL |
| Gallic acid quercetin | Induction of apoptosis and inhibition of key steps of metastasis | NM | [ |
|
| ||||||||
|
| Leaf | HCT116 | NM |
| Benzophenones, xanthones, and caged xanthones | Potent inhibitory cytotoxicities | NM | [ |
| Stem, bark | HCT116 | 14.23, 23.95 |
| Xerophenone A, doitunggarcinones A and B, sampsonione, 7 | NM | NM | [ | |
|
| ||||||||
|
| Fruit | Caco-2 | 400 mg/L |
| Chlorogenic acid, (+)catechin, (–)epicatechin, isoquercetin, rutin, phloridzin, procyanidin B2, phloretin, quercetin | WNT inhibitors and reduced WNT activity elicited by WNT5A | NM | [ |
|
| ||||||||
|
| Fruit | Caco-2 | 400 mg/L |
| Chlorogenic acid, (+)catechin, (–)epicatechin, isoquercetin, rutin, phloridzin, procyanidin B2, phloretin, quercetin | WNT inhibitors and reduced WNT activity elicited by WNT5A | NM | [ |
|
| ||||||||
|
| Leaf | HCT116 | 0.5, 1 mg/mL |
| Coixspirolactam A, coixspirolactam B, coixspirolactam C, coixlactam, methyl dioxindole-3-acetate | NM | Inhibited migration, invasion, and adhesion via repression of the ERK1/2 and Akt pathways under hypoxic conditions | [ |
|
| ||||||||
|
| Stem, bark | HCT116, HT-29 | 3.3, 6.6, and 11.8 |
| Fractions ( | Downregulation of multiple tumor promoter | Upregulation of p53, Myc/Max, and TGF- | [ |
|
| ||||||||
|
| Root | SGC7901, BGC823 | 3 mg/mL |
| NM | NM | Proliferation and migration through targeting lncRNA-CCAT1 | [ |
|
| ||||||||
|
| Leaf | HT-29 CSCs | 2.25 |
| Oxalic, malic acid | NM | Inhibited expression of the Notch1 and | [ |
|
| ||||||||
|
| NM | HT-29 | NM |
| Protein, dietary fiber, the B vitamins, niacin, vitamin B6, manganese, phosphorus, carbohydrates | (i) Inhibited proliferation of cancer cells | Free radical scavenging activity | [ |
|
| ||||||||
|
| NM | COLO 205 and KM12 | 12.5 |
| n-Hexane, CH2Cl2, EtOAc, and MeOH fractions (A−D) | (i) Growth inhibitory activity | NM | [ |
|
| ||||||||
|
| Leaf | HCT116 | 5, 10, 20, 30, 40, 50 |
| Polyphenols | NM | Inhibited replication of DNA and transcription of RNA which induce the ROS | [ |
|
| ||||||||
|
| Fruit | SW480 | 25, 50, 100 |
| NM | NM | Mitochondria-related apoptosis and activation of p53 | [ |
|
| ||||||||
|
| NM | HCT116, SW-480 | <4, <20 |
| Rollitacin, jimenezin, membranacin, desacetyluvaricin, laherradurin | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | SW-480 | 0.5 | NM | Cherimolin-2 | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HT-29 | 1.47 |
| Purpurediolin, purpurenin, annoglaucin, annonacin A | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | NM | 3.6 |
|
| Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HT-29 | 2-10 | NM | Demethylencecalin | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | <20 |
| Fraction F-4, fraction F-5, ursolic acid | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 1.8×10−4 to 2.80 |
| Podophyllotoxin, | NM | (i) Inhibitor of microtubules | [ |
|
| ||||||||
|
| NM | HCT15 | <20 |
| Ursolic acid | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | <10 ( |
|
| Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | Col2 | <4, <20 | NM | Pectinolide A, pectinolide B, pectinolide C, | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | Col2 | <4,<20 | NM | Dehydro- | Nonspecific cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 2.8-12 |
|
| Nonspecific cytotoxic activity | NM | [ |
|
| ||||||||
|
| Leaf, root, stem | HF6, HT-29, HCT15 | 14.9, 12.7, 9.9 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | 3.5 to <1 ( |
| Salvileucalin B, Hex: leaf, Hex: stem, DCM: leaf, DCM: stem | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HT-29 | <4 |
| 1,2,4-trihydroxynonadecan, 1,2,4-trihydroxyheptadec-16-ene, 1,2,4-trihydroxyheptadec-16-yne | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| Roots, aerial parts | HF6 | 0.2, 0.5, 2.3 |
| DCM: MeOH, 6MPTOXPTOX | NM | (i) Induction of cell cycle arrest in G2/M | [ |
|
| ||||||||
|
| NM | HCT15 | 3.6, 3.9, and 4.3 | NM | Moronic acid | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | 18.70 |
| NM | Cytotoxic inactivity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | 0.63, 0.50, 1.99 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 12.64 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | 0.6 to 4.5 | NM | 10-Epi-uveoside, uveoside, picramnioside E, picramnioside D | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 15.19 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 6.74 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HF6 | 0.169 and 1.46 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT116, SW-480, SW-620 | NM | NM | 13-Hydroxy-10-oxo-trans-11-octadecenoic acid | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| NM | HCT15 | 10, 2.1, 9.1 |
| NM | Cytotoxic activity | NM | [ |
|
| ||||||||
|
| Seed, endosperm, and hull | HT-29 | 0.1–1,000 |
| Phytosterols (campesterol, stigmasterol, and | NM | (i) Influence of signal transduction pathways that involve the membrane phospholipids | [ |
|
| ||||||||
|
| Leaf | HT-29 | 210 |
| Flavonoids (4H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl, 2-ethoxy-4-vinylphenol, N,N′-dimethylglycine, lup-20(29)-en-3-one, linolenin, 1-mono-, 9-hexadecanoic acid methyl ester, linolenic acid methyl ester), phenolic (amino acids, terpenoids, fatty acids, methyl palmitoleate) | NM | (i) Increase in the levels of reactive oxygen species and simultaneous reduction in cellular antioxidant, mitochondrial membrane loss, DNA damage, and G1/S phase cell cycle arrest | [ |
|
| ||||||||
|
| NM | HCT116, HT-29 | 12.5, 25, 50, 100, 200 |
| Gallotannins | Increased contents of gallic acid and ellagic acid | (i) Induced apoptosis through the activation of caspases 3, 8, 9 | [ |
|
| ||||||||
|
| Powder | HCT116 | 20, 30, 40, 60, 80, 100 |
| Phenolic compounds | Inhibited cell viability and increased LDH release | (i) PTEN/p53/PDK1/Akt signal pathways through PTEN/p53 induce apoptosis | [ |
|
| ||||||||
|
| Powder | HCT116 | 100, 200, 400 |
| NM | NM | (i) Increased the sub-G1 population, mRNA levels of caspases 3 and 8, levels of I | [ |
|
| ||||||||
| Corn silk | NM | LoVo, HCT116 | 1.25, 2.5, 5, 10, 20 |
| Proteins, polysaccharides, flavonoid, vitamins, tannins, alkaloids, mineral salts, steroids | NM | (i) Increase in the Bax, cytochrome c, caspases 3 and 9 levels | [ |
|
| ||||||||
|
| Powder | HT-29 | 1, 2, 3, 4, 5 |
| Neoxanthin, all-trans- | NM | (i) Upregulation of p53 and p21 expression | [ |
|
| ||||||||
|
| Freeze-dried fruit | HT-29 | 1, 2.5, 5, 10, 20 |
| Delphinidin, cyanidin, petunidin, and peonidin | NM | (i) Increased intracellular ROS production | [ |
|
| ||||||||
|
| Fruit | Caco-2, DLD-1 | 200 |
| NM | NM | (i) Increased the phosphorylation of c-Jun N-terminal kinase (JNK) | [ |
|
| ||||||||
|
| Twigs | Caco-2 | 5, 50, 100, 250, or 500 |
| Flavonoid and triterpenic compounds | NM | (i) Increase in the levels of ROS | [ |
|
| ||||||||
|
| Peel and pulp | Caco-2 | 62.5, 125, 250, 500 |
| Polyphenols | Decreased production of reactive oxygen species (ROS) | NM | [ |
|
| ||||||||
|
| Leaf | HCT116 | 47, 63, 79, and 95 |
| Alkaloids | NM | (i) Downregulated DNA-binding and transcriptional activities of NF | [ |
|
| ||||||||
|
| NM | Caco-2 | 10-1,000 |
| 5-Caffeoylquinic acid (5-CQA), 3,5-dicaffeoylquinic acid (3,5-DCQA), ferulic acid (FA), caffeic acid (CA), dihydrocaffeic acid (DHCA), dihydroferulic acid (DHFA) | Reduced viability of cancer cells | NM | [ |
|
| ||||||||
|
| Leaf | HT-29 | NM |
| Phenolic compounds | NM | (i) Inhibition of IL-8 | [ |
∗NM: not mentioned.
(a) Efficacy of medicinal plants on colon cancer in in vivo models
| Scientific name | Parts used | Model | Dose | Type of extract | Important compounds | Cellular effect | Mechanisms | References | |
|---|---|---|---|---|---|---|---|---|---|
|
| Seed |
| Caco-2 |
|
| Procyanidins | (i) Increased crypt depth and growth-inhibitory effects | Reduced MPO (myeloperoxidase) activity | [ |
| Seed |
| HT-29, SW480 | 5 mg/kg |
| NM | NM | Decreased VEGF, TNF, MMP-1, MMP-3, MMP-7, MMP-8, MMP-9, and MMP-13 protein expression | [ | |
| Skin |
| NM | 7.5, 30, 60 |
| 4′-Geranyloxyferulic acid | NM | NM | [ | |
| Seed |
| NM | 0.12% |
| Catechin, epicatechin | NM | (i) Suppressed proliferation, sphere formation, nuclear translocation of | [ | |
|
| |||||||||
|
| Leaf |
| HT-29 | In vitro: 0, 10, 30, 50 |
| Catechin, epigallocatechin gallate | 1.9-fold increase in tumor endothelial cell apoptosis | Inhibited the ERK-1 and ERK-2 activation, VEGF expression, and VEGF promoter | [ |
|
| HCT116 | 0.5% | NM | NM | Reduced basement membrane | Inhibition of MMP-9 and VEGF secretion | [ | ||
|
| Caco-2, HT-29 | 300 |
| Theaflavins (TF-2, TF-3, TF-1) | Induced apoptosis of human colon cancer cells | Inhibition of edema formation correlated to attenuation of COX-2 expression and promoter analysis revealed modulation of NF | [ | ||
|
| HT115 | 25 |
| Phenolic compounds (p-hydroxyphenyl ethanol, pinoresinol & dihydroxyphenyl ethanol) | NM | Inhibition via reduced expression of a range of | [ | ||
|
| |||||||||
|
| Leaf |
| HT-29, HCT116 | 0, 100, 200, 300 mg/L |
| p-Coumaric acid, tricin | Inhibition of colony formation | (i) Nonadherent sphere formation suppressed CD133+ & CD44+ population | [ |
|
| |||||||||
|
| NM |
| CT26 | Oral dose of 50 & 10 mg/mouse per day |
| Kinsenoside | Stimulated proliferation of lymphoid tissues | Activation of phagocytosis of peritoneal macrophages | [ |
|
| |||||||||
|
| Fruit |
| Colon cancer stem cells | 5.0 |
| Anthocyanin, | Reduction in colon CSCs number and tumor incidence | (i) Increase in cytochrome c levels from p53 status and maybe mitochondria-mediated apoptosis | [ |
|
| |||||||||
|
| Leaf |
| HT-29 | Nm |
| Polysaccharides, oligosaccharides | Induction of apoptosis and inhibit proliferation | (i) Inactivation of the retinoblastoma phosphoprotein | [ |
|
| |||||||||
|
| Leaf |
| HT-29 | SC-RE 30 |
| Polyphenols (carnosic acid (CA) and carnosol) | (i) Activation of Nrf2 transcription factor | ||
| Leaf |
| NM | NM |
| Rosmanol and its isomers, carnosol, rosmadial, carnosic acid, and 12-methoxycarnosic acid, carnosic acid, carnosol | Interactions with the gut microbiota and by a direct effect on colonocytes with respect to the onset of cancer or its progression | NM | ||
|
| |||||||||
|
| Rhizomes |
| COLO 205 | 5 mg/mL |
| 6-(Methylsulfinyl)hexyl isothiocyanate | Anticolon cancer properties through the induction of apoptosis and autophagy | (i) Activation of TNF- | [ |
|
| |||||||||
|
| Rhizome | HT-29 | HT-29 | 5 g/kg |
| Turmerone | Suppressed the proliferation of HT-29 colon cancer cells | (i) LDH release | [ |
|
| |||||||||
|
| Root |
| NM | 30 mg/kg |
| Ginsenosides (protopanaxadiol or protopanaxatriol) | Attenuated azoxymethane/DSS-induced colon carcinogenesis by reducing the colon tumor number and tumor load | (i) Reduced experimental colitis | [ |
|
| |||||||||
|
| Leaf |
| HCT116 | 100 |
| Phenolics, flavonoids, betulinic acid | Inhibition of tumor angiogenesis | (i) Inhibition of angiogenesis of tube formation on Matrigel matrix and HUVECS migration ( | [ |
|
| |||||||||
|
| Leaf |
| HT-29 | 200 mg/mL ( |
| Rosmarinic acid | Induction of apoptosis and inhibition of cell proliferation and tumor angiogenesis | (i) Induced apoptosis | [ |
|
| |||||||||
|
| Aerial part |
| NM | 500 |
| Gymnasterkoreaynes B, C, E, 2,9,16-heptadecatrien-4,6-dyne-8-ol | Anti-inflammatory and cancer preventive activities | (i) Significant decrease in expression of COX-2 | [ |
|
| |||||||||
|
| Edible portions |
| CT26 | 50 mg/kg b.w. |
| p-Coumaric acid, ferulic acid, sinapic acid, quercitrin, isoquercitrin, quercetol, kaempferol | Suppression of tumor growth and enhanced survival rate of test mice | (i) Decreased expression of inflammatory molecular markers | [ |
|
| |||||||||
|
| Leaf |
| HCT116 | 8.98 |
| Acetogenins (annoreticuin & isoannoreticuin) and alkaloids dopamine, salsolinol, and coclaurine | (i) Inhibited growth and proliferation of tumor cells | Reactive oxygen species (ROS) formation, lactate dehydrogenase (LDH) release, and caspases 3/7, 8, 9 activation | [ |
|
| |||||||||
|
| Aerial parts |
| HT-29 | 25 |
| Pyrrolizidine alkaloids (senecionine, senkirkine, monocrotaline, echimidine) | Cytotoxicity against colon cancer cells | (i) Upregulation of p21 and downregulation of NCL, FOS, and AURKA, indicating reduced proliferation capacity | [ |
|
| |||||||||
|
| Aerial parts |
| HCT116 | 500 |
| Phenolic glucoside (flacourticin, 4′-benzoylpoliothrysoside) | Antiproliferative and proapoptotic effects in HCT116 cells | Apoptosis via generation of ROS and activation of caspases (PARP) | [ |
|
| |||||||||
|
| The dermal layer of stalk |
| HCT116 & colon cancer stem cells | >16 and 103 |
| Apigeninidin & luteolinidin | Antiproliferative effect | (i) Target p53-dependent and p53-independent pathways | [ |
|
| |||||||||
|
| Thorn |
| HCT116 | 800 |
| Flavonoid, lupine acid, ellagic acid glycosides | Inhibited proliferation of colon cancer | (i) Increased p53 levels | [ |
| Thorn |
| HCT116 | 600 |
| NM | Inhibitory effect on the proliferation of human colon cancer HCT116 cells | (i) Caused G2/M phase cell cycle arrest | [ | |
|
| |||||||||
|
| Rhizome |
| HCT116 | 5 |
| 6-Paradol, 6- and 10-dehydrogingerdione, 6- and 10-gingerdione, 4-, 6-, 8-, and 10-gingerdiol, 6-methylgingerdiol, zingerone, 6-hydroxyshogaol, 6-, 8-, 10-dehydroshogaol, diarylheptanoids | Inhibitory effects on the proliferation of human colon cancer cells | (i) Arrest of G0/G1 phase | [ |
|
| |||||||||
|
| The enzymatically hydrolyzed epithelium of the edible |
| HCT116 | <150 |
| Monosulphated triterpenoid glycoside frondoside A, the disulphated glycoside frondoside B, the trisulphated glycoside frondoside C | (i) Inhibition at S and G2-M phase with a decrease in Cdc25c | (i) Inhibition the growth of human colon | [ |
|
| |||||||||
|
| Leaf & twigs |
| HT-29 | 10 and 5 mg/kg/day |
| Sesquiterpene lactone (13-acetoxyrolandrolide) | Antiproliferative effect against human colon cancer cells | (i) Inhibition of the NF | [ |
|
| |||||||||
|
| Leaf & fruit |
| Caco-2 | 250–500 |
| Phenolic compound (flavonol and flavone heterosides, 5-O-caffeoylquinic acid) | Antiproliferative effect against human kidney and colon cancer cells | (i) Suppression of NF | [ |
|
| |||||||||
|
| Aerial part |
| HT-29 | 0–0.5 mg/mL |
| Buddlejasaponin IV | Induced apoptosis in HT-29 human colon cancer cells | (i) Induced apoptosis via mitochondrial-dependent pathway triggered by downregulation of Bcl-2 protein levels, caspase 3 activation, and subsequent PARP cleavage | [ |
|
| |||||||||
|
| Caps & stalks |
| HT-29 | 0-0.1 mg/mL |
| Polysaccharides (mainly glucans & glycoproteins), triterpenes (ganoderic acids, ganoderic alcohols, and their derivatives) | Cytokine expression inhibited during early inflammation in colorectal carcinoma | Induced autophagy through inhibition of p38 mitogen-activated kinase and activation of farnesyl protein transferase (FPT) | [ |
|
| |||||||||
|
| Fruit & leaf |
| HT-29 | 20–320 mg/L |
| Terpene lactones and flavonoid glycosides | Inhibited progression of human colon cancer cells induced HT-29 cell apoptosis | (i) Activation in caspase 3, reduction in Bcl-2 expression, and elevation in p53 expression | [ |
|
| |||||||||
|
| Fruit |
| JB6 Cl 41 | 25 |
|
| Inhibited tumor development | (i) Impaired signal transduction pathways leading to activation of AP-1 and NFB RU-ME fraction | [ |
|
| |||||||||
|
| Seed |
| HT-29, SW 480, HCEC | 100 |
| Phenolic compound (tricin, ferulic acid, caffeic acid, and methoxycinnamic acid) | Inhibited growth of human colon cancer cells | (i) Induction of apoptosis by enhanced activation of caspases 8 and 3 | [ |
|
| |||||||||
|
| Dried stem |
| SW480 | In vivo: 0.4 g/kg/day |
| Polysaccharides, phenylethanoid glycosides | Decreased mucosal hyperplasia and helicobacter infection | (i) Increased number of splenic macrophages and NK cells | [ |
|
| |||||||||
|
| NM |
| CT26 | 28 mg/kg |
| Catalpol | (i) Inhibited proliferation, growth, and expression of angiogenic markers | (i) VEGF, VEGFR2, HIF-1 | [ |
|
| |||||||||
|
| Olive mill wastewater |
| NM | NM |
| Hydroxytyrosol | Interferes with tumor cell growth | NM | [ |
| Leaf |
| HCT116, HCT8 | 0, 5, 10, 20, 30, 50, and 70 |
| Oleuropein and hydroxytyrosol | NM | (i) Activation of caspases 3, 7, and 9 | [ | |
|
| |||||||||
|
| Leaf |
| NM | 0.675 and 1.35 g/kg |
| Flavonoid glycosides, terpene lactones, and ginkgolic acids | (i) Suppressed tumor cell proliferation, promoted apoptosis, and mitigated inflammation | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg, 100 mg/kg |
| Tannic acid, gallic acid | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| SW-480 | 1.5, 7.5 mg/kg/day | NM | Laherradurin | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 250/500 mg/kg |
| A, B, and C, and cis- and trans-annomuricin-D-ones | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 200 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 350 mg/kg/day |
| Flavonoids, sesquiterpenoids, monoterpenoids, acetylenes, p-acetophenones, benzopyrans, benzofurans | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 175 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 100 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 200 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg/day, 350 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 50 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 400 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| NM |
| NM | 350 mg/kg/day |
| NM | Cytotoxic activity | NM | [ |
|
| |||||||||
|
| Flower |
| HT-29 | 150 mg/kg |
| Isocoreopsin, butrin, and isobutrin | Free radical scavenging and anticancer activities | NM | [ |
|
| |||||||||
|
| Root |
| HT-29, HCT116 | 40 mg/kg/day |
|
| Induced programmed cell death | NM | [ |
∗NM: not mentioned.
(b) Other effects of medicinal plants in in vivo models
| Scientific name | Parts used | Model | Dose | Type of extract | Important compounds | Cellular effect | Mechanisms | References | |
|---|---|---|---|---|---|---|---|---|---|
|
| Root |
| NM | 2.4 mL of daily |
| Allicin, S-allylmercaptocysteine | Significantly suppressed both the size and number of colon adenomas | Enhancement of detoxifying enzymes: SAC and GST activity | [ |
|
| |||||||||
|
| Fruit |
| Caco-2 | 50 |
| Phenolic compounds, authentic hydroxyl tyrosol (HT) | (i) Effect of OPE and HT on CB1 associated with reduced proliferation of Caco-2 cells | Increase in Cnr1 gene expression, CB1 protein levels | [ |
|
| HT115 | 25 |
| Phenolic compounds (p-hydroxyphenyl ethanol, pinoresinol & dihydroxyphenyl ethanol) | NM | Inhibition via reduced expression of a range of | [ | ||
|
| |||||||||
|
| Leaf |
| NM | 20, 40, 60 mg·kg−1 |
| Rosmarinic acid, caffeic acid, flavonoids | Antioxidant status | (i) Increased LPO products and activity of SOD and CAT enzymes and GST and GPx activity | [ |
|
| |||||||||
|
| Skin |
| NM | The flow rate 0.21 mL/min and injection volume 9.4 |
| Flavan-3-ols, in monomeric and polymeric forms, and phenolic acids | (i) Decreased circulating levels of free fatty acids and triglycerides | Increase of the total antioxidant capacity of plasma | [ |
|
| |||||||||
|
| Fruit |
| NM | 90 mg/L |
| Phenolic acids, flavonoids, tannins, stilbenes, curcuminoids | NM | NM | [ |
|
| |||||||||
|
| Fruit |
| HT-29 | 10 ng/mL |
| Phenolic compounds (pyrogallol, caffeic acid, myricetin, protocatechuic acid, etc.) | Inhibition of TNBS-induced rat colitis | (i) Induced cell cycle progression in G0/G1 phase and apoptotic death | [ |
|
| |||||||||
|
| Leaf |
| NM | 250 |
| Rutin, gallic acid, catechin hydrate, naringin | Oxidative profile in patients with colon cancer | NM | [ |
|
| |||||||||
|
| Dry flower & leaf |
| DLD-1 and HCT116 | 0.3–5 |
| Cannabidiol, phytocannabinoids | NM | (i) Reduced cell proliferation in a CB1-sensitive and AOM-induced preneoplastic lesions and polyps | [ |
|
| |||||||||
|
| Fruit |
| SW480, CT26 | 0, 10, 20, 30, 40, 50 |
| Triterpenoids, flavonoids, polysaccharide, limonoids | NM | (i) Inhibited cell proliferation of SW480 and CT26 by promoting apoptosis as indicated by nuclear chromatin condensation and DNA fragmentation | [ |
|
| |||||||||
|
| Root |
| NM | 73.90, 150.74, 147.65, and 123.26 mg/kg |
| Fructans | NM | Reduction incidence of colon tumors expressing altered | [ |
|
| |||||||||
|
| Peel |
| NM | 4.5 g/kg |
| Gallic acid, protocatechuic acid, cateachin, rutin, ellagic acid, punicalagin | NM | (i) Reduction in TGF- | [ |
|
| |||||||||
|
| Seed |
| NM | 500 mg/kg |
| Secoisolariciresinol diglucoside, carbohydrates, proteins, and tannins | Reduced the serum fasting glucose levels | Significantly reduced the HbA1c, insulin levels, and proinflammatory cytokines | [ |
|
| |||||||||
|
| Fruit |
| NM | 15 mg/kg |
| Polyphenol | (i) Decreased attenuation of colon length in diarrhea severity | Decreased expression of COX-2 and iNOS in the colonic tissue | [ |
|
| |||||||||
|
| Leaf |
| NM | 50, 250, 500 mg/kg |
| Rutin, gallic acid, ferulic acid, and pinocembrin | Reduction of the colonic oxidative stress, increasing the antioxidants levels possibly via the synergistic action of several flavonoids | NM | [ |
|
| |||||||||
|
| NM |
| HT-29 CSCs | 2.25 |
| NM | Regulatory and target genes that mediate the Notch signal transduction pathway | Inhibition of expression of the Notch1 and | [ |
|
| |||||||||
|
| Gel |
| NM | 400 mg/kg/day |
| Polysaccharides | NM | (i) Via inhibition of the cell cycle progression | [ |
|
| |||||||||
|
| Powder |
| HCT116 | 20, 40 mg/kg/day |
| Phenolic compounds | NM | (i) Induced apoptosis via PTEN/p53/PDK1/Akt signal pathways through PTEN/p53 | [ |
|
| |||||||||
|
| Powder |
| HT-29 | 2 g/kg and 1 g/kg |
|
| NM | (i) Promoted tumor apoptosis by upregulating the mRNA expression of Bax and caspase 3 and downregulating the mRNA expression of Bcl-2 and cyclin D1 | [ |
|
| |||||||||
|
| Leaf |
| NM | 125, 250, 500 mg/kg |
| Quercetin-3-rhamnose | NM | (i) Decreased the levels of IL-22, MPO levels, proliferation of epithelial cells | [ |
|
| |||||||||
|
| Stem, bark |
| HCT116 | 2,000 mg/kg/day |
| Resin and essential oils | NM | NM | [ |
|
| |||||||||
|
| NM |
| NM | 50 and 100 mg/kg |
| NM | NM | NM | [ |
|
| |||||||||
|
| Bark |
| NM | 100 and 400 mg/kg |
| Catechin, catechol, and salicin | NM | Decreased level of EGFR, nuclear | [ |
Figure 1Cell damage and cancer trigger p53 activation. The p53 protein activates the apoptotic protein Bax. Bax inhibits the antiapoptotic protein Bcl-2. During apoptosis, cytochrome c is released from mitochondria. To activate the Apaf-1 protein, the interaction between these proteins and cytochrome C is necessary. Pro-caspase 9 attaches to Apaf-1 and activates caspase 9. Caspase 9 activates caspases 3 and 7 and apoptosis occurs.